key: cord-0786367-ospkjamc
authors: Sacci, Peter; Au, Arthur; Hutchinson, Morgan
title: E‐cigarette or vaping product use‐associated lung injury (EVALI) characterized by pulmonary ultrasound
date: 2020-06-30
journal: J Am Coll Emerg Physicians Open
DOI: 10.1002/emp2.12181
sha: 96ba1c29e6a28c08e104e805cf482d24457518a4
doc_id: 786367
cord_uid: ospkjamc

Pulmonary ultrasound is a useful tool in the diagnosis and resuscitation of emergency department (ED) patients with dyspnea. We present the case of a patient who was diagnosed with E‐cigarette or vaping product use‐associated lung injury (EVALI) using pulmonary ultrasound. Many of these cases are diagnosed using x‐ray, computerized tomography, or bronchoscopy and to our knowledge this is the first published case that demonstrates utility of ultrasound in diagnosing EVALI. While more investigation is needed on the use of this technique, the patient in this case was diagnosed with EVALI based on positive history, presence of normal cardiac function, non‐cardiogenic pulmonary edema on ultrasound, and absence of pulmonary infection.

E-cigarette use, or vaping, is increasingly prevalent as a modality for tobacco and tetrahydrocannabinol (THC) consumption. The long-term effects of electronic cigarette use are not yet known due to its relative infancy, but E-cigarette or vaping product use-associated lung injury (EVALI) has become a recognized condition. EVALI is a spectrum of disease that includes diffuse alveolar hemorrhage, lipoid pneumonia, acute eosinophilic pneumonia, hypersensitivity pneumonitis, and organizing pneumonia. 1, 2 Patients may present to the hospital with a myriad of symptoms that can include dyspnea, cough, chest pain, exercise intolerance, gastrointestinal upset and interventions required may range from simple monitoring to supplemental oxygen administration, mechanical ventilation, extracorporeal membrane oxygenation, and lung transplant. 3 Due to the diverse nature of complaints, the differential diagnosis in these cases is broad and includes pneumonia, bronchitis, pulmonary edema secondary to cardiac or noncardiac causes, obstructive lung disease, pulmonary embolism, and acute coronary syndrome. Diagnosis is made by clinical history and imaging suggestive of lung injury. Imaging with chest x-ray and computerized 

A previously healthy 26-year-old male with a medical history of exercise-induced asthma and e-cigarette use presented with dyspnea and cough for 9 days. The patient presented to the hospital in November of 2019, before the Covid-19 pandemic. He was evaluated at an urgent care where he was diagnosed with pneumonia and placed on doxycycline. He remained symptomatic and was seen in an outside hospital ED where azithromycin was added. Two days prior to presentation to our ED he was again seen at urgent care and given albuterol/ipratroprium nebulizer treatments, an intramuscular dose of dexamethasone, and levofloxacin. One day prior to arrival he developed blood-tinged sputum. His last use of e-cigarettes containing THC was 5 days prior to arrival, though he reported over 1 year of using THC-containing canisters.

On presentation to our ED, the patient was found to be hypoxemic to 88% on room air and tachypneic. He was placed on 2L O 2 by nasal cannula with some improvement in symptoms and vital signs. 

EVALI represents a spectrum of disease with a broad range of symptom severity. Pulmonary ultrasound is widely recognized as an important aid in the evaluation of dyspneic ED patients, and this case highlights its utility in diagnosing this emerging disease. More research is needed to determine its sensitivity in diagnosing EVALI and whether ultrasound findings correlate with symptom severity or disease progression.

Peter Sacci MD https://orcid.org/0000-0002-7081-6879

Pulmonary illness related to E-Cigarette use in illinois and Wisconsin -Final report

Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung injury (EVALI): evolving knowledge and remaining questions

E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach

Pediatric chest radiographic and CT findings of electronic cigarette or vaping product useassociated lung injury (EVALI)

Diagnosis of EVALI: general approach and the role of bronchoscopy

BLUE-protocol and FALLS-protocol: two applications of lung ultrasound in the critically ill

International evidencebased recommendations for point-of-care lung ultrasound

The air bronchogram: sonographic demonstration

Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI

Update: interim guidance for health care providers evaluating and caring for patients with suspected E-cigarette, or vaping, product use associated lung injury -United States

How to cite this article

E-cigarette or vaping product use-associated lung injury (EVALI) characterized by pulmonary ultrasound